Gerresheimer AG got off to a good start in the new financial year, announcing: "We continued on our successful course in the new financial year. We expect particularly strong growth over the coming years in emerging countries. Our latest acquisition of the Brazilian company Vedat strengthens our position in the merging markets and expands our product portfolio," said Gerresheimer's CEO, Uwe Rohrhoff. In Q1 of 2011 (ending 28 Feb/11), Gerresheimer substantially increased its revenues with a 5.2% rise to EUR 236.6M. At constant exchange rates, the growth rate was 2.9%. There was also a further rise in demand for cosmetics products. "Worldwide demand for medicines will continue to rise in the coming years. Demographic change, increasing incidence of acute and chronic diseases, growth of self-medication and the need for healthcare in emerging countries will contribute to this. These megatrends provide the basis for our future growth. With products and services we can contribute to improving health and well-being," says Rohrhoff.
